Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 3/2015

01.11.2015 | Original Article

Cardiovascular risk profile, diabetes specific factors, and prevalent microvascular eye complications in sub-Saharan Africans with type 2 diabetes

verfasst von: Andre P. Kengne, Patricia Gouking, Edvine Wawo, Godefroy Koki, Eric Balti, Herbert Hakapoka, Mesmin Y. Dehayem, Eugene Sobngwi, Jean-Claude Mbanya

Erschienen in: International Journal of Diabetes in Developing Countries | Sonderheft 3/2015

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to examine the association between cardiovascular risk profile, diabetes-specific factors, and prevalent retinopathy in sub-Saharan Africans with type 2 diabetes. We enrolled 213 (41 % women) diabetic adults from the Cameroon National Obesity Center in 2008. Prevalent retinopathy was based on history and digital mydriatic retinal photography. Cardiovascular risk profile was assessed, and global absolute coronary risk was estimated with the UK Prospective Diabetes Study (UKPDS) and Framingham coronary risk equations. Logistic regressions were used to relate risk factors to prevalent retinopathy and discrimination and calibration assessed. Fifty-four patients (25.4 %) had prevalent of retinopathy. Patients with retinopathy had more often hypertension (88 vs 43 %, p = 0.003), and age at diagnosis, known duration of diabetes, blood glucose, and systolic blood pressure were associated with retinopathy. Estimated 10-year coronary risks by the Framingham and UKPDS had low discrimination for retinopathy, with C-statistic (95 % confidence interval) of 0.593 (0.504–0.682) and 0.603 (0.518–0.688), respectively. New equations developed from this sample had better discrimination and calibration, with a maximum C-statistic of 0.881 (0.828–0.933). Cardiovascular risk profile was poorly correlated with prevalent retinopathy in this population. Strategies based upon routinely assessed diabetes-related factors can improve the selection of patients at high risk of retinopathy for costly confirmatory investigations.
Literatur
1.
Zurück zum Zitat International Diabetes Federation. Diabetes Atlas. 4th ed. Brussels: IDF. 2009. International Diabetes Federation. Diabetes Atlas. 4th ed. Brussels: IDF. 2009.
2.
Zurück zum Zitat Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.PubMedCrossRef Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.PubMedCrossRef
3.
Zurück zum Zitat Kengne AP, Patel A, Marre M, Travert F, Lievre M, Zoungas S, et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil. 2011;18(3):393–8. doi: 0.1177/1741826710394270. Kengne AP, Patel A, Marre M, Travert F, Lievre M, Zoungas S, et al. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil. 2011;18(3):393–8. doi: 0.1177/1741826710394270.
4.
Zurück zum Zitat Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009;55(2):92–6.PubMedCrossRef Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009;55(2):92–6.PubMedCrossRef
5.
Zurück zum Zitat Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes. 2010;3:153.PubMedPubMedCentralCrossRef Chatziralli IP, Sergentanis TN, Keryttopoulos P, Vatkalis N, Agorastos A, Papazisis L. Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2. BMC Res Notes. 2010;3:153.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869–75.PubMedCrossRef Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology. 2008;115(11):1869–75.PubMedCrossRef
7.
Zurück zum Zitat Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a south Indian type 2 diabetic population—the Chennai urban rural epidemiology study (CURES) Eye study 4. Diabet Med. 2008;25(5):536–42.PubMedCrossRef Pradeepa R, Anitha B, Mohan V, Ganesan A, Rema M. Risk factors for diabetic retinopathy in a south Indian type 2 diabetic population—the Chennai urban rural epidemiology study (CURES) Eye study 4. Diabet Med. 2008;25(5):536–42.PubMedCrossRef
8.
Zurück zum Zitat Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147(5):448–57.PubMedCrossRef Dowse GK, Humphrey AR, Collins VR, Plehwe W, Gareeboo H, Fareed D, et al. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol. 1998;147(5):448–57.PubMedCrossRef
9.
Zurück zum Zitat Owens DR, Volund A, Jones D, Shannon AG, Jones IR, Birtwell AJ, et al. Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients. Diabetes Res. 1988;9(2):59–65.PubMed Owens DR, Volund A, Jones D, Shannon AG, Jones IR, Birtwell AJ, et al. Retinopathy in newly presenting non-insulin-dependent (type 2) diabetic patients. Diabetes Res. 1988;9(2):59–65.PubMed
10.
Zurück zum Zitat Kengne AP, Djouogo CF, Dehayem MY, Fezeu L, Sobngwi E, Lekoubou A, et al. Admission trends over 8 years for diabetic foot ulceration in a specialized diabetes unit in Cameroon. Int J Low Extrem Wounds. 2009;8(4):180–6.PubMedCrossRef Kengne AP, Djouogo CF, Dehayem MY, Fezeu L, Sobngwi E, Lekoubou A, et al. Admission trends over 8 years for diabetic foot ulceration in a specialized diabetes unit in Cameroon. Int J Low Extrem Wounds. 2009;8(4):180–6.PubMedCrossRef
11.
Zurück zum Zitat D’Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.PubMedCrossRef D’Agostino Sr RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743–53.PubMedCrossRef
12.
Zurück zum Zitat Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101(6):671–9.CrossRef Stevens RJ, Kothari V, Adler AI, Stratton IM. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond). 2001;101(6):671–9.CrossRef
13.
Zurück zum Zitat Koki G, Bella AL, Omgbwa EA, Epee E, Sobngwi E, Kouanang KA, et al. [Diabetic retinopathy in black Africans: an angiographic study]. Sante. 2010;20(3):127–32.PubMed Koki G, Bella AL, Omgbwa EA, Epee E, Sobngwi E, Kouanang KA, et al. [Diabetic retinopathy in black Africans: an angiographic study]. Sante. 2010;20(3):127–32.PubMed
14.
Zurück zum Zitat Massin P, Angioi-Duprez K, Bacin F, Cathelineau B, Cathelineau G, Chaine G, et al. Detection, monitoring and treatment of diabetic retinopathy. Recommendations of ALFEDIAM. Committee of above-mentioned experts and validated by the board of directors and scientific board of ALFEDIAM. Diabetes Metab. 1996;22(3):203–9.PubMed Massin P, Angioi-Duprez K, Bacin F, Cathelineau B, Cathelineau G, Chaine G, et al. Detection, monitoring and treatment of diabetic retinopathy. Recommendations of ALFEDIAM. Committee of above-mentioned experts and validated by the board of directors and scientific board of ALFEDIAM. Diabetes Metab. 1996;22(3):203–9.PubMed
15.
Zurück zum Zitat Nguyen HT, Luzio SD, Dolben J, West J, Beck L, Coates PA, et al. Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus. J Diabetes Complications. 1996;10(4):211–9.PubMedCrossRef Nguyen HT, Luzio SD, Dolben J, West J, Beck L, Coates PA, et al. Dominant risk factors for retinopathy at clinical diagnosis in patients with type II diabetes mellitus. J Diabetes Complications. 1996;10(4):211–9.PubMedCrossRef
16.
Zurück zum Zitat Al-Zuabi H, Al-Tammar Y, Al-Moataz R, Al-Sabti K, Wani VB, Hamama F, et al. Retinopathy in newly diagnosed type 2 diabetes mellitus. Med Princ Pract. 2005;14(5):293–6.PubMedCrossRef Al-Zuabi H, Al-Tammar Y, Al-Moataz R, Al-Sabti K, Wani VB, Hamama F, et al. Retinopathy in newly diagnosed type 2 diabetes mellitus. Med Princ Pract. 2005;14(5):293–6.PubMedCrossRef
17.
Zurück zum Zitat Chen MS, Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol. 1992;114(6):723–30.PubMedCrossRef Chen MS, Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ, et al. Prevalence and risk factors of diabetic retinopathy among noninsulin-dependent diabetic subjects. Am J Ophthalmol. 1992;114(6):723–30.PubMedCrossRef
18.
Zurück zum Zitat Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130(6):515–24.PubMedCrossRef Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130(6):515–24.PubMedCrossRef
19.
Zurück zum Zitat Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, et al. The Framingham and UKPDS risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the action in diabetes and vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) study. Diabetologia. 2010;53(5):821–31.PubMedCrossRef Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, et al. The Framingham and UKPDS risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the action in diabetes and vascular disease: preterax and diamicron-MR controlled evaluation (ADVANCE) study. Diabetologia. 2010;53(5):821–31.PubMedCrossRef
20.
Zurück zum Zitat International Diabetes Federation. Global guidelines for type 2 diabetes. Brussels: International Diabetes Federation, 2005. International Diabetes Federation. Global guidelines for type 2 diabetes. Brussels: International Diabetes Federation, 2005.
21.
Zurück zum Zitat Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol. 2010;90(2):109–14. doi:10.1111/j.1755-3768.2010.01882.x. Mehlsen J, Erlandsen M, Poulsen PL, Bek T. Individualized optimization of the screening interval for diabetic retinopathy: a new model. Acta Ophthalmol. 2010;90(2):109–14. doi:10.1111/j.1755-3768.2010.01882.x.
22.
Zurück zum Zitat Zoppini G, Verlato G, Targher G, Casati S, Gusson E, Biasi V, et al. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? Nutr Metab Cardiovasc Dis. 2009;19(5):334–9.PubMedCrossRef Zoppini G, Verlato G, Targher G, Casati S, Gusson E, Biasi V, et al. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes? Nutr Metab Cardiovasc Dis. 2009;19(5):334–9.PubMedCrossRef
23.
Zurück zum Zitat Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up. Diabetes Res Clin Pract. 2010;89(3):296–302.PubMedCrossRef Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y. The effect of fasting plasma glucose variability on the risk of retinopathy in type 2 diabetic patients: retrospective long-term follow-up. Diabetes Res Clin Pract. 2010;89(3):296–302.PubMedCrossRef
24.
Zurück zum Zitat Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Diabetes Metab. 2009;35(3):214–9.PubMedCrossRef Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients. Diabetes Metab. 2009;35(3):214–9.PubMedCrossRef
25.
Zurück zum Zitat Arden GB, Sivaprasad S. The pathogenesis of early retinal changes of diabetic retinopathy. Doc Ophthalmol Adv Ophthalmol. 2012;124(1):15–26.CrossRef Arden GB, Sivaprasad S. The pathogenesis of early retinal changes of diabetic retinopathy. Doc Ophthalmol Adv Ophthalmol. 2012;124(1):15–26.CrossRef
26.
Zurück zum Zitat Swanson M. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost—an epidemiologic review. Optometry. 2005;76(11):636–46.PubMedCrossRef Swanson M. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost—an epidemiologic review. Optometry. 2005;76(11):636–46.PubMedCrossRef
27.
Zurück zum Zitat Li HK, Horton M, Bursell SE, Cavallerano J, Zimmer-Galler I, Tennant M, et al. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011;17(10):814–37.PubMedCrossRef Li HK, Horton M, Bursell SE, Cavallerano J, Zimmer-Galler I, Tennant M, et al. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011;17(10):814–37.PubMedCrossRef
28.
Zurück zum Zitat Van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med. 2000;19(24):3401–15.PubMedCrossRef Van Houwelingen HC. Validation, calibration, revision and combination of prognostic survival models. Stat Med. 2000;19(24):3401–15.PubMedCrossRef
29.
Zurück zum Zitat Grobbee D. HA. Clinical epidemiology: principle, methods and applications for clinical research: Jones & Bartlett. 2008. Grobbee D. HA. Clinical epidemiology: principle, methods and applications for clinical research: Jones & Bartlett. 2008.
Metadaten
Titel
Cardiovascular risk profile, diabetes specific factors, and prevalent microvascular eye complications in sub-Saharan Africans with type 2 diabetes
verfasst von
Andre P. Kengne
Patricia Gouking
Edvine Wawo
Godefroy Koki
Eric Balti
Herbert Hakapoka
Mesmin Y. Dehayem
Eugene Sobngwi
Jean-Claude Mbanya
Publikationsdatum
01.11.2015
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe Sonderheft 3/2015
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-014-0283-y

Weitere Artikel der Sonderheft 3/2015

International Journal of Diabetes in Developing Countries 3/2015 Zur Ausgabe